САЩ - английски - NLM (National Library of Medicine)

sohm inc. - aluminum hydroxide (unii: 5qb0t2iun0) (aluminum hydroxide - unii:5qb0t2iun0), magnesium carbonate (unii: 0e53j927na) (carbonate ion - unii:7ujq5ope7d) - relieves - heartburn - acid indigestion - sour stomach - upset stomach associated with these symptoms

САЩ - английски - NLM (National Library of Medicine)

laboratorios imperiales, s.a. de c.v. - aluminum hydroxide (unii: 5qb0t2iun0) (aluminum hydroxide - unii:5qb0t2iun0), bismuth subcarbonate (unii: m41l2in55t) (bismuth cation - unii:zs9cd1i8ye), calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), magnesium carbonate (unii: 0e53j927na) (carbonate ion - unii:7ujq5ope7d), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37) - aluminum hydroxide 0.18 g in 3.5 g - purpose antacid uses - for the relief of heartburn, sour stomach, and acid indigestion

САЩ - английски - NLM (National Library of Medicine)

natural creations, inc. - magnesium carbonate (unii: 0e53j927na) (carbonate ion - unii:7ujq5ope7d), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), aesculus hippocastanum flower (unii: kk0z92ii8m) (aesculus hippocastanum flower - unii:kk0z92ii8m), potassium alum (unii: 1l24v9r23s) (aluminum hydroxide - unii:5qb0t2iun0), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), strychnos nux-vomica seed (unii: 269 - magnesium carbonate 3 [hp_x] in 1 ml - uses: temporarily relieves great straining, large, dry, hard, knotty stools, &/or other symptoms of constipation. uses: temporarily relieves great straining, large, dry, hard, knotty stools, &/or other symptoms of constipation.

САЩ - английски - NLM (National Library of Medicine)

natural creations, inc. - magnesium carbonate (unii: 0e53j927na) (carbonate ion - unii:7ujq5ope7d), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), horse chestnut (unii: 3c18l6rjaz) (horse chestnut - unii:3c18l6rjaz), potassium alum (unii: 1l24v9r23s) (aluminum hydroxide - unii:5qb0t2iun0), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomic - uses: temporarily relieves great straining, large, dry, hard, knotty stools, &/or other symptoms of constipation.** uses: temporarily relieves great straining, large, dry, hard, knotty stools, &/or other symptoms of constipation.**

САЩ - английски - NLM (National Library of Medicine)

natural creations, inc. - magnesium carbonate (unii: 0e53j927na) (carbonate ion - unii:7ujq5ope7d), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), horse chestnut (unii: 3c18l6rjaz) (horse chestnut - unii:3c18l6rjaz), potassium alum (unii: 1l24v9r23s) (aluminum hydroxide - unii:5qb0t2iun0), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomic - uses: temporarily relieves symptoms of constipation.** uses: temporarily relieves symptoms of constipation.**

САЩ - английски - NLM (National Library of Medicine)

hospira, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

САЩ - английски - NLM (National Library of Medicine)

hospira, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium (mg++ ) level is usually below the lower limit of normal (1.5 to 2.5 meq/liter) and the serum calcium (ca++ ) level is normal (4.3 to 5.3 meq/liter) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection, usp is also indicated for the prevention and control of seizures (convulsions) in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

САЩ - английски - NLM (National Library of Medicine)

hospira, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 10 mg in 1 ml - magnesium sulfate in 5% dextrose injection is indicated for: magnesium sulfate in 5% dextrose injection is contraindicated in patients: risk summary magnesium sulfate in 5% dextrose injection is indicated in pregnant women for the prevention of eclampsia in women with preeclampsia and the treatment of seizures and prevention of recurrent seizures in women with eclampsia. fetal, neonatal, and maternal risks are discussed throughout the labeling. clinical considerations labor or delivery: magnesium sulfate in 5% dextrose injection is not approved for the treatment of pre-term labor. administration of magnesium sulfate in 5% dextrose injection to pregnant women longer than 5 to 7 days may lead to hypocalcemia and bone abnormalities in the developing fetus, including skeletal demineralization and osteopenia [see warnings and precautions (5.1)] . the use of intravenous magnesium in pregnant women increases human milk magnesium concentrations only slightly and oral absorption of magnesium by the infant is poor. the

САЩ - английски - NLM (National Library of Medicine)

wg critical care, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 4 g in 100 ml - magnesium sulfate in water for injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. when used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. however, other effective drugs are available for this purpose. intravenous magnesium should not be given to mothers with toxemia of pregnancy during the two hours preceding delivery.

САЩ - английски - NLM (National Library of Medicine)

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.